Developing an ‘allogeneic stem cell-derived photoreceptor cell product’ compatible with good manufacturing practice (GMP) conditions.
Fields of Study & Subjects
Retinal Development and Disorders
Pluripotent Stem Cells Research
Retinal Diseases and Treatments
Publication details
- Journal / source
- Therapeutic Innovation Australia
- Publication date
- 17 February 2026
- Language
- EN